Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

27/09/2017


Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Bad Vilbel, September 27, 2017 –

At today’s constituent meeting, the Supervisory Board of STADA Arzneimittel AG elected Dr. Günter von Au as its new Chairman.
On September 26, 2017 the District Court of Frankfurt am Main appointed Jan-Nicolas Garbe, Benjamin Kunstler, Bruno Schick, Dr. Michael Siefke and Dr. Günter von Au as new members of the Supervisory Board with immediate effect after the former Chairman of the Supervisory Board along with four other members of the Supervisory Board had stepped down from their offices as of the end of September 25, 2017 (see the Company’s ad hoc release of August 25, 2017).

Contact:
STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2–18 / 61118 Bad Vilbel – Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: leslie.iltgen@stada.de

Download in PDF format

Share:

Related Posts

STADA Arzneimittel AG confirms receipt of non-binding expressions of interest in takeover bid
STADA Arzneimittel AG confirms receipt of non-binding expressions of interest in takeover bid
STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018
The Supervisory Board of STADA Arzneimittel AG appointed Peter Goldschmidt today as new Chairman of the Executive Board as of September 1, 2018.
STADA Arzneimittel AG informs about receipt of binding, conditional take-over offer
STADA Arzneimittel AG informs about receipt of binding, conditional take-over offer